Compass Therapeutics’ new drug, tovecimig, is making serious waves in the cancer world. Analysts think it could become the go-to treatment for people with tough-to-treat bile duct cancer, possibly outperforming the current standard. With thousands of patients eligible and blockbuster sales predicted, this could be huge for both patients and investors. Plus, there’s buzz it might work for other cancers too. Watch this space! #Health #BodyHealth #CancerResearch